|
|
Volumn 93, Issue 12, 2012, Pages 1245-1251
|
|
Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.
a
a
not available
*
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOGEN;
IMMUNOSUPPRESSIVE AGENT;
MITOGEN ACTIVATED PROTEIN KINASE P38;
PHORBOL 13 ACETATE 12 MYRISTATE;
PHOSPHOPROTEIN;
TACROLIMUS;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CYTOLOGY;
DOSE RESPONSE;
DRUG EFFECT;
FEMALE;
FLOW CYTOMETRY;
GRAFT REJECTION;
HUMAN;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
LEUKEMIA CELL LINE;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
ADULT;
CARCINOGENS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLOW CYTOMETRY;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
JURKAT CELLS;
KIDNEY TRANSPLANTATION;
MALE;
MAP KINASE SIGNALING SYSTEM;
MIDDLE AGED;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHOPROTEINS;
PHOSPHORYLATION;
T-LYMPHOCYTES;
TACROLIMUS;
TETRADECANOYLPHORBOL ACETATE;
|
|
EID: 85027957172
PISSN: None
EISSN: 15346080
Source Type: None
DOI: 10.1097/tp.0b013e318250fc62 Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
